We attended the scientific-practical conference “Brain Stimulation. Challenges in Regulation and Implementation: Latest Insights and Examples” at VU Medical Sciences Center, Vilnius, on 19 September 2025. The programme covered psychiatry, neurology, emerging applications, women’s health, and a practical session on clinical implementation.
Prof. Ch. Baeken outlined clinical applications in psychiatry with attention to current levels of evidence, followed by Prof. A. Antal on neurology and later on regulation, safety, and certification. Dr. J. Bjekic surveyed emerging applications. Dr. E. Radyte presented neurotechnology for women’s health with Samphire Neuroscience as an example. A practical discussion chaired by Neuropulsas addressed how these therapies work in real settings.
For OPORA Health, these sessions map directly onto our remit: rigorous evidence capture, privacy-preserving workflows, and audit-ready data for regulated studies. We focus on making endpoints traceable, session and protocol metadata unambiguous, and governance demonstrable to monitors and regulators. This is the infrastructure that turns promising clinical practice into verifiable evidence.
Our takeaway is operational. Trials need harmonised outcomes, consistent device and session records, and complete provenance from consent to analysis. We will continue working with study teams using OPORA Health to strengthen these foundations so results are reproducible and submission-ready. Conference details and session titles are drawn from the published programme.
